Hypertronics Circular HyperGrip® Connectors Selected for Biosense Webster's CARTO® 3 Navigation System

DN Staff

April 21, 2010

2 Min Read
Hypertronics Circular HyperGrip® Connectors Selected for Biosense Webster's CARTO®  3 Navigation System

MATERIALS: Hypertronics Corp. announced that their HyperGrip® series circular connectors were selected by Biosense Webster Inc. for their new Carto® 3 Navigation System. Hypertronics HyperGrip (HG) series was chosen for their optimal signal reliability and ease of use as a push pull connector.

Hypertronics Hypertac® system is a unique contact design characterized by a wire basket technology which encapsulates a male pin and guarantees continuous signal integrity especially critical in medical  applications where machine failure is often life threatening. HyperGrip is a user-configurable circular connector which is color-coded and customer-keyable for accurate and quick connections on medical equipment. HyperGrip is designed to meet medical industry requirements such as finger-proofing to IEC60601, flammability rated to UL94 V0, and is compatible with most sterilization requirements.  HyperGrip also incorporates the legendary performance of the Hypertac® contact technology which provides high mating cycle, low insertion force and the high reliability required for the medical market.

The Carto® 3 System provides views of the electrical activity of the heart through real-time data on 3-D, color-coded cardiac maps. It also ensures precise real-time tracking of catheter location, allowing for safe and accurate diagnosis. Designed to minimize RF applications, unnecessary radiation exposure and procedure times, the Carto® System 3 Navigation System improves location accuracy and site-targeting results while maintaining an excellent safety profile. The CARTO® 3 System offers three unique features: Advanced Catheter Location (ACL) Technology, Fast Anatomical Mapping (FAM), and a streamlined workflow feature set referred to as CONNECTION OF CHOICETM. These three features work in tandem to enhance a physician’s ability to treat an array of simple and complex cardiac arrhythmias.

The CARTO® 3 System is currently under 510(k) review at the U.S. Food and Drug Administration for use in the U.S. The CARTO® 3 System will be released throughout the European Union and Canada in the third quarter of 2009.


-Edited by Kelsey Anderson

Sign up for the Design News Daily newsletter.

You May Also Like